These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 12947742)

  • 1. [Community-acquired Pseudomonas aeruginosa bacteremic pneumonia in a "healthy" subject].
    Illinger J; Mohammedi I; Martin O; Argaud L; St Denis M; Robert D
    Presse Med; 2003 Jul; 32(24):1123. PubMed ID: 12947742
    [No Abstract]   [Full Text] [Related]  

  • 2. [The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
    Vitkauskiene A; Sakalauskas R; Dudzevicius V
    Medicina (Kaunas); 2003; 39(3):254-9. PubMed ID: 12695638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community acquired Pseudomonas aeruginosa pneumonia.
    Vikram HR; Shore ET; Venkatesh PR
    Conn Med; 1999 May; 63(5):271-3. PubMed ID: 10363405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-acquired Pseudomonas aeruginosa infection in an infant.
    Hendricks MK; Senekal M
    Ann Trop Paediatr; 1996 Sep; 16(3):203-6. PubMed ID: 8893949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of adequate empirical combination therapy on mortality from bacteremic Pseudomonas aeruginosa pneumonia.
    Park SY; Park HJ; Moon SM; Park KH; Chong YP; Kim MN; Kim SH; Lee SO; Kim YS; Woo JH; Choi SH
    BMC Infect Dis; 2012 Nov; 12():308. PubMed ID: 23157735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia.
    Wu CL; Lee YL; Chang KM; Chang GC; King SL; Chiang CD; Niederman MS
    Crit Care Med; 2003 Mar; 31(3):812-7. PubMed ID: 12626989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults: case report and review of the literature.
    Hatchette TF; Gupta R; Marrie TJ
    Clin Infect Dis; 2000 Dec; 31(6):1349-56. PubMed ID: 11096001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
    Tennenberg AM; Davis NB; Wu SC; Kahn J
    Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot tub-associated necrotizing pneumonia due to Pseudomonas aeruginosa.
    Crnich CJ; Gordon B; Andes D
    Clin Infect Dis; 2003 Feb; 36(3):e55-7. PubMed ID: 12539092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study.
    Paulsson M; Granrot A; Ahl J; Tham J; Resman F; Riesbeck K; Månsson F
    Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1187-1196. PubMed ID: 28110415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum.
    Traugott KA; Echevarria K; Maxwell P; Green K; Lewis JS
    Pharmacotherapy; 2011 Jun; 31(6):598-608. PubMed ID: 21923444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticarcillin therapy of risk patients with infections due to Pseudomonas aeruginosa.
    Welter J; Wittman DH; Freitag V
    J Int Med Res; 1981; 9(1):44-51. PubMed ID: 7202830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should Pseudomonas aeruginosa isolates resistant to one of the fluorinated quinolones be tested for the others? Studies with an experimental model of pneumonia.
    Chidiac C; Roussel-Delvallez M; Guery B; Beaucaire G
    Antimicrob Agents Chemother; 1995 Mar; 39(3):677-9. PubMed ID: 7793872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of fulminant community-acquired Pseudomonas aeruginosa necrotizing pneumonia in a previously healthy young man.
    Kunimasa K; Ishida T; Kimura S; Tanaka M; Kouyama Y; Yamashita S; Morita M; Tachibana H; Tokioka F; Ito A; Sumi C; Tateda K
    Intern Med; 2012; 51(17):2473-8. PubMed ID: 22975571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
    Kim J; Kang CI; Baek JY; Cho SY; Kim SH; Ko KS; Chung DR; Peck KR; Song JH
    Int J Antimicrob Agents; 2014 Apr; 43(4):391-3. PubMed ID: 24637223
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental Pseudomonas aeruginosa sepsis: absence of synergy between ticarcillin and tobramycin.
    Chusid MJ; Davis SD; Sarff LD
    J Lab Clin Med; 1983 Mar; 101(3):441-9. PubMed ID: 6402553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orbital cellulitis and endophthalmitis in pseudomonas septicemia.
    Luemsamran P; Pornpanich K; Vangveeravong S; Mekanandha P
    Orbit; 2008; 27(6):455-7. PubMed ID: 19085303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleral buckle infection with ciprofloxacin-resistant Pseudomonas aeruginosa.
    Chaudhry NA; Tabandeh H; Rosenfeld PJ; Miller D; Davis J
    Arch Ophthalmol; 1998 Sep; 116(9):1251. PubMed ID: 9747696
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudomonas aeruginosa keratitis treated with ticarcillin and tobramycin.
    Prociv P
    Med J Aust; 1979 Jul; 2(2):63-4. PubMed ID: 114740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia.
    Paul M; Leibovici L
    Lancet Infect Dis; 2005 Apr; 5(4):192-3; discussion 193-4. PubMed ID: 15792730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.